Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Cagrilintide vs tirzepatide (Mounjaro/Zepbound) Mechanism: Cagrilintide: Amylin agonist Tirzepatide: Dual GIP/GLP-1 agonist Both novel approaches Weight loss: Cagrilintide: 10-12% monotherapy Tirzepatide: 15-22% monotherapy Tirzepatide superior as single agent Administration: Both: Weekly subcutaneous injection Both: Similar convenience Side effects: Cagrilintide: Strong GI effects Tirzepatide: Moderate GI effects Similar overall profile Approval status: Cagrilintide: Investigational Tirzepatide: FDA approved Tirzepatide available now Cost (when both available): Likely similar ($1,000-1,500/month) Both premium weight loss options Verdict: Currently, tirzepatide better choice (approved, superior weight loss)
Ongoing research ensures peptide therapies are continuously evolving to expand their potential for improving overall health and well-being
Restylane (HA filler) Known for precision and versatility
Retinoids remain gold standard for collagen stimulation through retinoic acid receptor activation
Neither AOD 9604 nor retatrutide holds a Marketing Authorisation from the MHRA, meaning selling or supplying them with therapeutic claims in the UK is illegal under the Human Medicines Regulations 2012
US$ 22.57
US$ 23.27
US$ 24.98
US$ 27.29
US$ 28.39
US$ 20.88
US$ 26.53
US$ 25.19
US$ 20.79
US$ 23.56
US$ 29.65
